VNS Algorithm for Advanced Dosing
for Epilepsies
1 location in Augusta
Sponsor: Fernando Vale
Sex: All·Age: 18 - 75
Code: NCT07725601·Recruiting·Listed Jul 24, 2026
Paid Clinical Trials in Augusta, GA
As of August 2026, 174 paid clinical trials are recruiting in Augusta, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Augusta offers studies at sites including Augusta University Medical Center for conditions such as Acute Myeloid Leukemia, Ovarian Cancer, Sickle Cell Disease, Cervical Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Augusta
Trials by drug in Augusta
Filter results
Filter results
Newly added in Augusta
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
161 clinical trials
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for Parkinson Disease
Sites in Augusta +29 more locations
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All·Age: 30 - 80
Code: NCT07432958·Phase 2·Recruiting·Listed Feb 2026
A Study of Brenipatide in Adult Participants With Schizophrenia
for Schizophrenia
Drug: Brenipatide
Sites in Augusta, Atlanta +30 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 55
Code: NCT07410507·Phase 2·Recruiting·Listed Feb 2026
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for Hepatitis
Drug: Larsucosterol
Sites in Augusta, Atlanta +82 more locations
Sponsor: Bausch Health Americas, Inc.
Sex: All·Age: 18+
Code: NCT07428538·Phase 3·Recruiting·Listed Feb 2026
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
for Neovascular Age-Related Macular Degeneration (nAMD)
Drug: Ixo-vec
Sites in Augusta +78 more locations
Sponsor: Adverum Biotechnologies, Inc.
Sex: All·Age: 50+
Code: NCT07482176·Phase 3·Recruiting·Listed Mar 2026
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for Non-Small Cell Lung Cancer (NSCLC)
Drug: Pumitamig
Sites in Augusta, Athens +39 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07361510·Phase 3·Recruiting·Listed Jan 2026
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
for Parkinson's Disease
Sites in Augusta, Atlanta +24 more locations
Sponsor: Bayer
Sex: All·Age: 45 - 75
Code: NCT07330258·Recruiting·Listed Jan 2026
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: Pegcetacoplan
Sites in Augusta +77 more locations
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All·Age: 60+
Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
for Elevated Lp(a)
Drug: Muvalaplin
Sites in Augusta, Gainesville +138 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for Ovarian Cancer
Drug: INCB123667
Sites in Augusta, Atlanta +46 more locations
Sponsor: Incyte Corporation
Sex: Female·Age: 18+
Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for Proteinuric Kidney Disease
Sites in Augusta, Savannah +164 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 10 - 65
Code: NCT05312879·Phase 2, Phase 3·Recruiting·Listed Apr 2022
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
for Age-related Macular Degeneration (AMD)
Drug: Cemdisiran
Sites in Augusta, Marietta +139 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 50 - 85
Code: NCT06541704·Phase 3·Recruiting·Listed Aug 2024
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
for Cervical Cancer
Sites in Augusta, Atlanta +126 more locations
Sponsor: Pfizer
Sex: Female·Age: 18+
Code: NCT06952660·Phase 4·Recruiting·Listed May 2025
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for Neovascular Age-related Macular Degeneration
Drug: Surabgene Lomparvovec
Sites in Augusta +51 more locations
Sponsor: AbbVie
Sex: All·Age: 50+
Code: NCT07007065·Phase 3·Recruiting·Listed Jun 2025
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Augusta, Evans +2366 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for Large B-cell Lymphoma
Sites in Augusta +60 more locations
Sponsor: Allogene Therapeutics
Sex: All·Age: 18+
Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for Solid Tumors
Sites in Augusta, Marietta +40 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for Diabetes Mellitus, Type 2
Sites in Augusta, Macon +121 more locations
Sponsor: Cleerly, Inc.
Sex: All·Age: 55+·Accepts healthy volunteers
Code: NCT06112418·Recruiting·Listed Nov 2023
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
for Migraine
Drug: Rimegepant
Sites in Augusta +27 more locations
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT05156398·Phase 3·Recruiting·Listed Dec 2021
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
for Neovascular Age-related Macular Degeneration
Drug: Ranibizumab
Sites in Augusta +32 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 50+
Code: NCT04853251·Phase 4·Recruiting·Listed Apr 2021
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
for High Grade Epithelial Ovarian Cancer
Sites in Augusta +36 more locations
Sponsor: Genmab
Sex: All·Age: 18+
Code: NCT05579366·Phase 1, Phase 2·Recruiting·Listed Oct 2022
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
for Heart Failure
Sites in Augusta, Atlanta +29 more locations
Sponsor: Procyrion
Sex: All·Age: 21+
Code: NCT05677100·Recruiting·Listed Jan 2023
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
for Parkinson Disease
Sites in Augusta, Atlanta +43 more locations
Sponsor: Neuron23 Inc.
Sex: All·Age: 40 - 80
Code: NCT06680830·Phase 2·Recruiting·Listed Nov 2024
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
for Geographic Atrophy
Sites in Augusta +53 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: All ages
Code: NCT06779773·Recruiting·Listed Jan 2025
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
for Bronchiectasis
Sites in Augusta, Atlanta +14 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT06872892·Phase 3·Recruiting·Listed Mar 2025
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for Ovarian Cancer
Sites in Augusta, Atlanta +31 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: Female·Age: 18+
Code: NCT06824467·Phase 3·Recruiting·Listed Feb 2025
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
for Interstitial Lung Diseases
Drug: Nerandomilast
Sites in Augusta, Atlanta +31 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06806592·Phase 3·Recruiting·Listed Feb 2025
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for Superficial Bladder Cancer
Sites in Augusta, Atlanta +46 more locations
Sponsor: enGene, Inc.
Sex: All·Age: 18+
Code: NCT04752722·Phase 1, Phase 2·Recruiting·Listed Feb 2021
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
for Non-cystic Fibrosis Bronchiectasis
Sites in Augusta, Atlanta +26 more locations
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All·Age: 18 - 80
Code: NCT06559150·Phase 2·Recruiting·Listed Aug 2024
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
for B-cell Malignancy
Sites in Augusta, Newnan +26 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT05006716·Phase 1, Phase 2·Recruiting·Listed Aug 2021
DALY II USA/ MB-CART2019.1 for DLBCL
for Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Sites in Augusta, Atlanta +26 more locations
Sponsor: Miltenyi Biomedicine GmbH
Sex: All·Age: 18+
Code: NCT04792489·Phase 2·Recruiting·Listed Mar 2021
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for Treatment Resistant Depression
Sites in Augusta, Atlanta +51 more locations
Sponsor: LivaNova
Sex: All·Age: 18+
Code: NCT03887715·Recruiting·Listed Mar 2019
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
for Heart Failure
Sites in Augusta, Atlanta +55 more locations
Sponsor: Abbott Medical Devices
Sex: All·Age: 18+
Code: NCT06526195·Recruiting·Listed Jul 2024
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for Pulmonary Embolism
Sites in Augusta +54 more locations
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT04798261·Recruiting·Listed Mar 2021
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
for Sickle Cell Disease
Drug: Etavopivat
Sites in Augusta, Atlanta +21 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 2+
Code: NCT06609226·Phase 3·Recruiting·Listed Sep 2024
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
for Relapsed Non-Hodgkin Lymphoma
Sites in Augusta +31 more locations
Sponsor: Lyell Immunopharma, Inc.
Sex: All·Age: 18+
Code: NCT05826535·Phase 1, Phase 2·Recruiting·Listed Apr 2023
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
for Generalized Myasthenia Gravis
Drug: Telitacicept
Sites in Augusta +25 more locations
Sponsor: Vor Biopharma
Sex: All·Age: 18+
Code: NCT06456580·Phase 3·Recruiting·Listed Jun 2024
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
for Focal Epilepsy
Drug: BHV-7000
Sites in Augusta +47 more locations
Sponsor: Biohaven Therapeutics Ltd.
Sex: All·Age: 18 - 75
Code: NCT06132893·Phase 2, Phase 3·Recruiting·Listed Nov 2023
Nectero EAST System Clinical Study
for Abdominal Aortic Aneurysm
Sites in Augusta +32 more locations
Sponsor: Nectero Medical, Inc.
Sex: All·Age: 21 - 85
Code: NCT06001918·Phase 2, Phase 3·Recruiting·Listed Aug 2023
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
for Cardiovascular Risk
Drug: Ziltivekimab
Sites in Augusta +27 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT06118281·Phase 3·Recruiting·Listed Nov 2023
Galleri® in the Medicare Population.
for Cancer
Sites in Augusta, Atlanta +59 more locations
Sponsor: GRAIL, Inc.
Sex: All·Age: 50+·Accepts healthy volunteers
Code: NCT05673018·Recruiting·Listed Jan 2023
Top Research Study Locations in Augusta
Researchers run research studies in Augusta, GA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Augusta University Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia | 39 |
| Augusta University | Sickle Cell Disease, Focal Epilepsy, Acute Myocardial Infarction (AMI) | 34 |
| Georgia Cancer Center at Augusta University | Cervical Cancer, Ovarian Cancer, AML With Mutated NPM1 | 13 |
| Southeast Retina Center | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Geographic Atrophy Secondary to Age-related Macular Degeneration | 4 |
| Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology | Osteo Arthritis Knee, Type 1 Diabetes, Whole Body Vibration | 3 |
| Georgia Cancer Center | Ovarian Cancer, Solid Tumor, cGVHD | 3 |
| Southeast Retina Center, P.C. | Epiretinal Membrane, Geographic Atrophy, Macular Degeneration | 3 |
| Aiyan Diabetes Center | Diabetes Mellitus, Type 2, Diabetic Foot Ulcer, Metabolic Syndrome | 2 |
| Augusta Oncology Associates PC-D'Antignac | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 2 |
| Augusta Oncology Associates PC-Wheeler | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 2 |
| Augusta University Georgia | Sickle Cell Disease | 2 |
| Augusta University Georgia Cancer Center | Breast Adenocarcinoma, Endometrial Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC) | 2 |
| Augusta University Health | Neuroblastoma | 2 |
| Augusta University, Georgia Cancer Center | Ependymoma, Glioblastoma, Medulloblastoma | 2 |
| Children's Hospital of Georgia | Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult | 2 |
| Piedmont Augusta Hospital | Acute Decompensated Heart Failure, Cardiovascular Diseases, Heart Diseases | 2 |
| Southeastern Clinical Research Institute | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), End Stage Kidney Disease (ESRD) | 2 |
| Augusta University - Georgia Cancer Center | Acute Myeloid Leukaemia (AML), Fallopian Tube Cancer, Ovarian Cancer | 2 |
| AOS Surgery Center | Lumbar Spinal Stenosis | 1 |
| AU Medical Center | Degenerative Disc Disease, Neuropathic Pain, Spinal Cord Injuries | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Alliance Spine and Pain Ctrs | Lumbar Spinal Stenosis | 1 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Augusta Cancer Center | B Cell Precursor Type Acute Leukemia, Chronic Myeloid Leukemia, Leukemia, Myeloid, Chronic | 1 |
| Augusta Pain Center | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Augusta (2026)
Recruiting trials in Augusta grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (64 active studies)
- Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive Pediatric Brain Cancer · Phase 1 · Lumos Pharma
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia · Phase 3 · Quetzal Therapeutics
Neurology & pain (10 active studies)
- Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury · Phase 1 · EicOsis Human Health Inc.
- A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations · Phase 2 · Appello Pharmaceuticals, Inc.
Eye & vision (9 active studies)
- Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration · VA Office of Research and Development
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Mental health & behavior (7 active studies)
- A Study of Brenipatide in Adult Participants With Schizophrenia · Phase 2 · Eli Lilly and Company
- Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD) · The University of Texas Health Science Center at San Antonio
Cardiovascular (7 active studies)
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) · Phase 3 · Reprieve Cardiovascular, Inc
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure · Abbott Medical Devices
Diabetes & metabolic (5 active studies)
- Assessing Obesity Related Risk Factors in Adult Population: A Genetic and Behavioral Study · Augusta University
- Lifestyle Intervention for Healthy Change · Augusta University
Pediatric (2 active studies)
Vaccines (1 active study)
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia · Phase 3 · UMC Utrecht
Common conditions studied in Augusta
- Acute Myeloid Leukemia (7 active studies)
- Ovarian Cancer (6 active studies)
- Sickle Cell Disease (6 active studies)
- Cervical Cancer (4 active studies)
- Endometrial Cancer (4 active studies)
- Malignant Solid Neoplasm (4 active studies)
Leading research sponsors in Augusta
- Augusta University
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Augusta?
There are approximately 174 recruiting clinical trials in Augusta, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Augusta pay participants?
Most recruiting trials in Augusta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Augusta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Augusta?
The most common conditions under active study in Augusta include Acute Myeloid Leukemia (7), Ovarian Cancer (6), Sickle Cell Disease (6), Cervical Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Augusta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Augusta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Augusta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Augusta?
Recruiting research sites in Augusta include Augusta University Medical Center, Augusta University, Georgia Cancer Center at Augusta University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Augusta right now?
The largest active categories in Augusta are Cancer & tumors (64), Neurology & pain (10), Eye & vision (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Georgia
Atlanta, GA(1,464)Decatur, GA(179)Savannah, GA(133)Marietta, GA(93)Macon, GA(71)Columbus, GA(63)Lawrenceville, GA(59)Athens, GA(54)Newnan, GA(51)Gainesville, GA(50)Johns Creek, GA(35)Stockbridge, GA(30)Snellville, GA(26)Fayetteville, GA(22)Sandy Springs, GA(21)Woodstock, GA(19)Albany, GA(18)Union City, GA(16)Brunswick, GA(15)Duluth, GA(15)Canton, GA(14)Roswell, GA(14)Tucker, GA(14)Thomasville, GA(13)Conyers, GA(12)Cordele, GA(11)Cumming, GA(11)Douglasville, GA(11)Norcross, GA(11)Peachtree Corners, GA(11)East Point, GA(10)Hinesville, GA(10)Alpharetta, GA(9)Dalton, GA(9)Stone Mountain, GA(9)Austell, GA(8)Riverdale, GA(8)Suwanee, GA(8)Braselton, GA(7)Tifton, GA(7)Valdosta, GA(7)Acworth, GA(6)Dunwoody, GA(6)Morrow, GA(6)Rincon, GA(6)Smyrna, GA(6)Cartersville, GA(5)Lilburn, GA(5)Buford, GA(4)Carrollton, GA(4)Dublin, GA(4)Jasper, GA(4)Kennesaw, GA(4)Peachtree City, GA(4)Ringgold, GA(4)Rome, GA(4)Stonecrest, GA(4)Warner Robins, GA(4)Adairsville, GA(3)College Park, GA(3)